glabridin has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullah, ST; Ahmed, I; Bag, S; Bhatt, S; Dhiman, S; Dogra, A; Gupta, D; Kumar, A; Nandi, U; Nehra, E; Sangwan, PL; Singh, G | 1 |
| Bag, S; Bhatt, S; Dogra, A; Kotwal, P; Kumar, A; Misra, P; Nandi, U; Sangwan, PL; Sharma, A; Sharma, P; Singh, G | 1 |
2 other study(ies) available for glabridin and Chemical and Drug Induced Liver Injury, Chronic
| Article | Year |
|---|---|
Glabridin ameliorates methotrexate-induced liver injury via attenuation of oxidative stress, inflammation, and apoptosis.
Topics: Animals; Antioxidants; Apoptosis; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Down-Regulation; Glycyrrhiza; Humans; Inflammation; Isoflavones; Liver; Methotrexate; Mice; NF-kappa B; Oxidative Stress; Phenols; Protective Agents; Tumor Necrosis Factor-alpha | 2021 |
Glabridin attenuates paracetamol-induced liver injury in mice via CYP2E1-mediated inhibition of oxidative stress.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Cytochrome P-450 CYP2E1; Isoflavones; Liver; Mice; Oxidative Stress; Phenols | 2022 |